These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 24593001)

  • 1. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
    Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
    Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
    Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
    J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.
    Hasanzadeh Kafshgari M; Alnakhli M; Delalat B; Apostolou S; Harding FJ; Mäkilä E; Salonen JJ; Kuss BJ; Voelcker NH
    Biomater Sci; 2015 Dec; 3(12):1555-65. PubMed ID: 26343506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
    Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
    Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular uptake mechanism and knockdown activity of siRNA-loaded biodegradable DEAPA-PVA-g-PLGA nanoparticles.
    Benfer M; Kissel T
    Eur J Pharm Biopharm; 2012 Feb; 80(2):247-56. PubMed ID: 22085653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression.
    Yuan H; Huang X; Li Q; Luo C; Lin C; Zhang S; Zhang Y; Yan Z; Du N; Liu Z; Jiang H; Chen B
    Biomed Pharmacother; 2022 Mar; 147():112672. PubMed ID: 35104698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery.
    Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY
    J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multifunctional Porous Silicon Nanocarrier for Glioblastoma Treatment.
    Luo M; Li Y; Peng B; White J; Mäkilä E; Tong WY; Jonathan Choi CH; Day B; Voelcker NH
    Mol Pharm; 2023 Jan; 20(1):545-560. PubMed ID: 36484477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
    Ma X; Zhao Y; Ng KW; Zhao Y
    Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delivery of Flightless I siRNA from Porous Silicon Nanoparticles Improves Wound Healing in Mice.
    Turner CT; Hasanzadeh Kafshgari M; Melville E; Delalat B; Harding F; Mäkilä E; Salonen JJ; Cowin AJ; Voelcker NH
    ACS Biomater Sci Eng; 2016 Dec; 2(12):2339-2346. PubMed ID: 33465882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tailoring the biodegradability of porous silicon nanoparticles.
    Hon NK; Shaposhnik Z; Diebold ED; Tamanoi F; Jalali B
    J Biomed Mater Res A; 2012 Dec; 100(12):3416-21. PubMed ID: 22767395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration.
    Van Woensel M; Wauthoz N; Rosière R; Mathieu V; Kiss R; Lefranc F; Steelant B; Dilissen E; Van Gool SW; Mathivet T; Gerhardt H; Amighi K; De Vleeschouwer S
    J Control Release; 2016 Apr; 227():71-81. PubMed ID: 26902800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-functionalized porous silicon nanoparticles for vectorization of hydrophobic drugs.
    Secret E; Smith K; Dubljevic V; Moore E; Macardle P; Delalat B; Rogers ML; Johns TG; Durand JO; Cunin F; Voelcker NH
    Adv Healthc Mater; 2013 May; 2(5):718-27. PubMed ID: 23203914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient functional delivery of siRNA using mesoporous silica nanoparticles with ultralarge pores.
    Na HK; Kim MH; Park K; Ryoo SR; Lee KE; Jeon H; Ryoo R; Hyeon C; Min DH
    Small; 2012 Jun; 8(11):1752-61. PubMed ID: 22454257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Porous silicon microparticles for delivery of siRNA therapeutics.
    Shen J; Wu X; Lee Y; Wolfram J; Yang Z; Mao ZW; Ferrari M; Shen H
    J Vis Exp; 2015 Jan; (95):52075. PubMed ID: 25651103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptide.
    Gao H; Zhang S; Yang Z; Cao S; Jiang X; Pang Z
    Int J Pharm; 2014 May; 466(1-2):8-17. PubMed ID: 24607217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximizing RNA Loading for Gene Silencing Using Porous Silicon Nanoparticles.
    Tieu T; Dhawan S; Haridas V; Butler LM; Thissen H; Cifuentes-Rius A; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Jul; 11(26):22993-23005. PubMed ID: 31252458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.